Atorvastatin 5mg + Fenofibrate 145mg Tablets

Atorvastatin + Fenofibrate is used for mixed lipid disorders where LDL cholesterol and triglycerides both need treatment. It may be used when lifestyle changes and a single lipid-lowering medicine have not provided adequate control.
Take the tablet whole with water with or after a meal, at a consistent daily time. Continue lipid, liver and kidney monitoring. Do not add another statin, fibrate or high-dose niacin without assessing the combined muscle and liver risks.
Atorvastatin blocks HMG-CoA reductase to reduce LDL production. Fenofibrate activates PPAR-alpha pathways that increase triglyceride clearance and alter lipoprotein metabolism. Together they target mixed cholesterol and triglyceride abnormalities.
Possible effects include stomach upset, nausea, headache, muscle aches, joint pain, constipation, diarrhoea, and abnormal liver or kidney tests. Serious warnings include severe muscle pain or weakness, dark urine, fever with muscle symptoms, jaundice, gallbladder-type pain, pancreatitis symptoms, or allergic swelling.
Use caution in kidney disease, liver disease, gallbladder disease, hypothyroidism, older age, heavy alcohol intake, diabetes, pregnancy, breastfeeding, and concurrent anticoagulants or other lipid medicines. Unexplained muscle symptoms should be reported promptly because statin-fibrate combinations can rarely cause serious muscle injury.
Targets both LDL cholesterol and triglyceride-rich lipids, supporting broader lipid control in patients who need combination therapy.
Atorvastatin 5mg + Fenofibrate 145mg is used for mixed lipid problems where both cholesterol and triglycerides need treatment.
Atorvastatin mainly lowers LDL, while fenofibrate helps lower triglycerides and improve triglyceride-rich lipid clearance.
Report unexplained muscle pain, weakness, tenderness, fever with muscle symptoms, or dark urine immediately.
Fenofibrate and statin-fibrate combinations need kidney monitoring because kidney impairment raises muscle and dosing risks.
Heavy alcohol can worsen triglycerides and liver risk, so alcohol intake should be discussed with the clinician.
No. A lipid-friendly diet, weight management, diabetes control, and activity remain central to treatment.
Fenofibrate: a fibrate medicine that lowers triglycerides. Mixed dyslipidaemia: abnormal levels of more than one type of blood lipid. PPAR-alpha: a receptor involved in regulation of fat metabolism. Myopathy: muscle injury or disease. Pancreatitis: inflammation of the pancreas.; AR: Atorvastatin 5mg + Fenofibrate 145mg أقراص; FR: Atorvastatin 5mg + Fenofibrate 145mg comprimés; PT: Atorvastatin 5mg + Fenofibrate 145mg comprimidos; ES: Atorvastatin 5mg + Fenofibrate 145mg comprimidos; RU: Atorvastatin 5mg + Fenofibrate 145mg таблетки; ID: Atorvastatin 5mg + Fenofibrate 145mg tablet; VI: Atorvastatin 5mg + Fenofibrate 145mg viên nén; MS: Atorvastatin 5mg + Fenofibrate 145mg tablet; TL: Atorvastatin 5mg + Fenofibrate 145mg mga tableta; ZH-SG: Atorvastatin 5mg + Fenofibrate 145mg 片剂
International B2B Enquiry
Send a structured B2B enquiry for Atorvastatin 5mg + Fenofibrate 145mg Tablets under Cardiac Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Atorvastatin 5mg + Fenofibrate 145mg Tablets